Common antibiotic boosts death risk: study - Outcome Magazine (blog)

IBNLive.com

Common antibiotic boosts death risk: study Outcome Magazine (blog) 05/20/2012 A popular antibiotic used for treating bronchitis, pneumonia, ear infections and sexually transmitted diseases may boost the risk of death, a US study said Wednesday. Azithromycin has been on the worldwide market since the 1980s, ... Popular Antibiotic May Be Responsible For Sudden Cardiac DeathRedOrbit Z-pack antibiotic poses 2.5-fold higher risk of cardiovascular deathTimes of India Popular Antibiotic May Raise Risk of Sudden DeathNew York Times Forbes all 160 news articles »

Study: Acupuncture may help some people with COPD - Fox News

MD News

Study: Acupuncture may help some people with COPD Fox News According to one researcher, the benefits seen with the alternative treatment were on par with, or better than, what's been shown for conventional drugs and exercises used to treat the disease. But the study was small, he added, and more research will ... Study: Acupuncture may relieve symptoms of COPDMother Nature Network (blog) all 22 news articles »

Acupuncture May Be Worth a Shot for COPD - WebMD

Acupuncture May Be Worth a Shot for COPD WebMD COPD is the umbrella term for chronic lung diseases, including chronic bronchitis and emphysema. It is often marked by a chronic cough and shortness of breath. Treatment typically involves the use of inhaled steroids and bronchodilators to open airways ... and more »

Popular Z-Pack Antibiotic Linked to Heart Issues - Christian Broadcasting Network

Popular Z-Pack Antibiotic Linked to Heart Issues Christian Broadcasting Network The drug is more expensive than other antibiotics, but popular for treating bronchitis, sinus infections, and other common illnesses because it's only a five-day medication. "If you are a patient who already has a high risk of heart problems, ...

Sunovion Announces Upcoming Availability of ZETONNA(TM) (ciclesonide) Nasal ... - MarketWatch (press release)

Sunovion Announces Upcoming Availability of ZETONNA(TM) (ciclesonide) Nasal ... MarketWatch (press release) ZETONNA Nasal Aerosol is FDA-approved for the treatment of SAR and PAR in adolescents and adults 12 years of age and older. It offers an alternative to conventional inhaled nasal sprays with water-based, aqueous delivery systems, some of which have ... and more »